Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... is also moving forward with its anti-CD200 program to include patients with multiple myeloma. 2009 Financial Guidance: Alexion is revising upward its previously announced guidance ... Acute Humoral Kidney Rejection (AHR) Soliris is also being investigated for the prevention of antibody-mediated rejection, also known as acute humoral rejection, in patients at ...
2009 APR 6 ... cancers, particularly non-Hodgkin's lymphoma, Hodgkin's disease, and multiple myeloma, besides breast and bladder cancers. However, in spite of this long standing evidence, ... Myeloma, Myeloma, Nausea, Non-Hodgkin Lymphoma, Oncology, Sleep Disorders, Cancer Prevention Coalition.
This article was prepared by Clinical Oncology Week editors ...
2009 JUN 22 ... Lymphoma, lung cancer, esophageal cancer, head and neck cancer, liver cancer, melanoma, myeloma, prostate cancer and pancreatic cancer. To find out more about the Goshen Center for ... cancer research - involved in and sponsoring a number of clinical trials in addition to prevention, screening, diagnostic, treatment and quality of life trials.
"We ...
2009 AUG 17 ... treatment-induced bone loss, rheumatoid arthritis, bone metastases, and multiple myeloma. A biologics license application (BLA) has recently been submitted to the ... to the U.S. Food and Drug Administration for Denosumab to be used in the treatment and prevention of postmenopausal osteoporosis in women and treatment and prevention of bone loss among ...
2009 NOV 16 ... Lymphoma, lung cancer, esophageal cancer, head and neck cancer, liver cancer, melanoma, myeloma, prostate cancer and pancreatic cancer. To find out more about the Goshen Center for ... for Cancer Care is involved in, and sponsors, a number of clinical trials. Additionally, prevention, screening, diagnostic and treatment trials are conducted at the Goshen Center for ...
2009 JUL 27 ... overexpressed in colon cancer, breast cancer, liver cancer, prostate cancer, multiple myeloma and melanoma, providing many potential cancer targets for this CSC vaccine in the ... Dr. Clemencia Pinilla, a specialist in immune response mechanisms and their role in the prevention and cause of human disease with over 100 publications and multiple patents to her ...
2009 JUN 29 ... lifelong monitoring as it is a pre-cancerous condition that can lead to multiple myeloma, a painful cancer of the plasma cells in the bone marrow. The study will appear in the ... blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular ...
2009 MAY 11 ... M.D., Ph.D., Harvard Medical School – "microRNAs as Key Regulators of Multiple Myeloma Pathogenesis"
- German Pihan, M.D., Beth Israel Deaconess Medical ... in Bodily Fluids"
- Kizee A. Etienne, Centers for Disease Control and Prevention Molecular Epidemiology Unit – "Luminex for Detection of Medically Significant ...
2009 MAY 11 ... greatest increase in incidence expected are: stomach (67 percent); liver (59 percent); myeloma (57 percent); pancreas (55 percent); and bladder (54 percent).
Given ... still have tremendously high mortality rates."
Unless specific prevention and/or treatment strategies are discovered, cancer death rates also will increase ...
Subject: University of Texas M. D. Anderson Cancer Center
2009 APR 13 ... 4. Update on Recent Developments for Patients with Newly Diagnosed Multiple Myeloma
Part II: Pediatric Oncology
5. Advances in the Management ... to their offering.
The exchange of ideas and knowledge concerning cancer prevention and methods for patient education is essential to giving patients all over the world ...
2009 NOV 16 ... the overall period", he concluded. 60 patients with diagnosis of lymphoma, myeloma, sarcoma, acute leukemia, and breast cancer were accrued. They were all receiving ... previously shown that a single dose of palonosetron effectively prevented CINV, with prevention rates higher than those obtained with the historical 5-HT3 receptor antagonists. The ...
2009 OCT 19 ... and use of denosumab in osteoporosis, breast cancer, prostate cancer, and multiple myeloma. Studies and abstracts were identified through MEDLINE and International Pharmaceutical ... significantly reduces bone resorption and fractures. Studies of denosumab in the prevention and treatment of osteoporosis have demonstrated significantly increased bone mineral ...
2009 NOV 2 ... Avenue South, New York, NY 10010-1707, USA. Keywords: Belgium, Brussels, Myeloma Prevention, Apoptosis, Bone Marrow, Caspase, Deacetylase, Drug Development, Drug Resistance, Enzyme ...
2009 JUL 13 ... For additional information, contact E. Anaissie, University of Arkansas, Myeloma Institute Research & Therapy, 4301 W Markham, Slot 776, Little Rock, AR 72205, USA. ... trends, new risk factors, and a timetable of infections, pathogens, therapy, and prevention of these infections," wrote M. Nucci and colleagues, University of Arkansas. ...
2009 AUG 31 ... resorption are among the most commonly prescribed drugs in the management of multiple myeloma (MM). Zoledronic acid (ZA) is a new generation potent intravenous bisphosphonate that ... potent intravenous bisphosphonate that has been approved for the treatment and prevention of bone lesions, and/or hypercalcemia associated with MM," researchers in Ankara, ...
2009 NOV 16 ... (DFCI), is Chief of the Division of Hematologic Neoplasia, Director of the Lipper Myeloma Center and Lebow Institute for Myeloma Therapeutics, and Vice Chair of the Joint Program ... blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular ...
2009 MAY 4 ... satisfaction of knowing they are raising money to find cures for leukemia, lymphoma and myeloma, and support services to help improve patients' lives.
Set against the ... coaching to help them meet their personal goals, and clinics on nutrition, injury prevention, gear and other essentials to prepare for the race. TNT also provides its participants a ...
2009 JUL 20 ... on race for a number of other cancers -- lung, colon, lymphoma, leukemia, and multiple myeloma. "The good news is that for most common cancers," Albain says, "if you ... are even detectable," he says. Meyskens is associate chair for Cancer Control and Prevention for the Southwest Oncology Group and director of the University of California-Irvine's ...
2009 MAY 18 ... Bisphosphonates are a family of drugs used to prevent and treat osteoporosis, multiple myeloma, Paget's disease (bone cancers), and bone metastasis from other cancers. These drugs ... report. Dr. Shetty states these findings are important news to learn about because early prevention and detection can halt permanent damage from happening to a patient's jawbone.
...
